Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Loxo Oncology presents next-generation RET inhibitor candidates

April 19, 2021

Shenzhen Targetrx Biotechnology synthesizes Ret inhibitors

April 19, 2021

Medshine Discovery presents new BTK inhibitors

April 19, 2021

Beijing Jacobio Pharmaceuticals divulges new KRAS inhibitors

April 19, 2021

Phase I study of eryaspase in first-line pancreatic cancer escalates to next cohort

April 19, 2021

Phase III study of chiauranib in SCLC begins

April 19, 2021

Ideaya reports preliminary phase I/II data on darovasertib in metastatic uveal melanoma

April 16, 2021

Phase II trial of TQ-B3525 for advanced gynecological cancers begins enrollment

April 16, 2021

Discovery of allosteric MALT1 protease inhibitor JNJ-67856633 for cancer

April 16, 2021

JNJ-74856665 mediates potent antileukemic activity and differentiation in preclinical models

April 16, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...